| Authors: |
Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Lim DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore., Kao HF; National Taiwan University Hospital, National Taiwan University Cancer Center, Taipei, Taiwan., Yeong J; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore., Oum C; Lunit, Seoul, Republic of Korea., Lee S; Lunit, Seoul, Republic of Korea., Lim Y; Lunit, Seoul, Republic of Korea., Ali SM; Lunit, Seoul, Republic of Korea., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore., Hui EP; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong, China.; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China., Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Park KU; Division of Hematology-Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea., Cho SH; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Gwangju, Republic of Korea., Lee KW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Chan ATC; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China., Ock CY; Lunit, Seoul, Republic of Korea., Ma B; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China. |
